Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | LSS | P48449 | 1/20 | 0.37 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.37 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.37 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7351088 | 0.95 | MEN1 (0.50) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL7350423 | 0.93 | MEN1 (0.47) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL7286646 | 0.85 | MEN1 (0.41) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL19835199 | 0.84 | HTT (0.43) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL9658698 | 0.84 | HTT (0.43) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL19835254 | 0.84 | HTT (0.43) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL5892540 | 0.82 | TSHR (0.52) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL27473945 | 0.81 | MEN1 (0.61) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL7285766 | 0.80 | S1PR2 (0.40) | MEN1KMT2AHTTTHRBMAPT | |
| SCHEMBL16608924 | 0.80 | GPR84 (0.50) | MEN1KMT2AMAPTTSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100284956-A1 | HAIR COSMETIC COMPOSITION | KAO CORPORATION (JP) | 2010-11-11 | — | — | US | disclosed |
| EP-2229933-A1 | HAIR COSMETIC COMPOSITION | Kao Corporation (JP) | 2010-09-22 | — | — | EP | disclosed |
| US-20100111885-A1 | Hair-Shape Controlling Composition | SHISEIDO COMPANY, LTD. (JP) | 2010-05-06 | — | — | US | disclosed |
| EP-2123250-A1 | HAIR-SHAPE CONTROLLING COMPOSITION | Shiseido Company, Limited (JP) | 2009-11-25 | — | — | EP | disclosed |
| US-20070166272-A1 | HAIR COSMETIC COMPOSITIONS AND PROCESS FOR PRODUCING THE SAME | KAO CORPORATION (JP) | 2007-07-19 | — | — | US | disclosed |
| EP-1808157-A1 | Hair cosmetic compositions and process for producing the same | Kao Corporation (JP) | 2007-07-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100284956-A1 | HAIR COSMETIC COMPOSITION | ADH1A, ADH1C, H1-0 | MEN1 1399/4885KMT2A 1061/4885HTT 626/4885 |
| US-20100111885-A1 | Hair-Shape Controlling Composition | DNMT3A, OGG1, DNMT1 | MEN1 4575/4885KMT2A 198/4885HTT 221/4885 |
| US-20070166272-A1 | HAIR COSMETIC COMPOSITIONS AND PROCESS FOR PRODUCING THE SAME | CUTA, SHH, POLR1C | MEN1 1290/4885KMT2A 1655/4885HTT 390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.